Company / PP&E (Net)
Zoetis PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$3.7B
FY2025
5-year range
$2.4B / $3.7B
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#10 of 193
Health Care
What the data says
Among 193 Health Care companies, Zoetis is in the top 5% for pp&e (net). PP&E (Net) has increased for 9 consecutive years, from $1.4B in FY2016 to $3.7B in FY2025.
Based on SEC 10-K filings.
$3.7B in FY2025 with a 5-year CAGR of +10.8%. Top quartile in the Health Care sector.
Improved from $3.2B to $3.7B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +10.2%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 193This company $3.7B Sector average $777.6M
▼
+373.3% above sector average
Key checks
Key Insights
- Zoetis's pp&e (net) has grown for 9 consecutive years.
- 5-year CAGR of +10.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 8.6% year-over-year.
- Ranks #10 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7B | +8.6% |
| FY2024 | $3.4B | +5.8% |
| FY2023 | $3.2B | +16.4% |
| FY2022 | $2.8B | +13.7% |
| FY2021 | $2.4B | +10.0% |
| FY2020 | $2.2B | +13.5% |
| FY2019 | $1.9B | +17.0% |
| FY2018 | $1.7B | +15.5% |
| FY2017 | $1.4B | +3.9% |
| FY2016 | $1.4B | +5.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026